Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹54470 Cr.
Stock P/E
66.4
P/B
1.6
Current Price
₹645.3
Book Value
₹ 411
Face Value
2
52W High
₹812
52W Low
₹ 565.3
Dividend Yield
0.93%

UPL Overview

Business

UPL Ltd. is a global provider of sustainable agriculture solutions. The company develops, manufactures, and markets a comprehensive portfolio of crop protection products, including herbicides, insecticides, fungicides, and plant growth regulators. Beyond conventional agrochemicals, UPL has a significant and growing presence in bio-solutions (bio-stimulants, bio-fungicides, bio-insecticides), seed treatment, and post-harvest solutions. Its core business model involves R&D for product development and formulation, manufacturing of active ingredients and formulations, and a vast global distribution network to deliver these solutions directly or indirectly to farmers worldwide. UPL makes money by selling these agricultural inputs, which help farmers enhance crop yield, quality, and resilience against pests and diseases.

Revenue Mix

UPL's revenue is primarily derived from its comprehensive portfolio of agricultural solutions. While it doesn't typically report distinct "segments" in the traditional sense, its business can be broadly categorized by product types and geographical regions:

Product Categories: Crop protection products (herbicides, fungicides, insecticides) form the largest part of the revenue. Bio-solutions are a rapidly growing segment. Other contributions come from seed treatment and post-harvest products.

Geographical Mix: UPL has a significant global presence. Its major markets include Latin America, North America, Europe, India, and the Rest of the World (including Africa, APAC). The company often highlights its diversified geographical exposure as a key strength.

Industry

The Pesticides & Agrochemicals industry is essential for global food security, driven by increasing population and demand for higher agricultural output. It is characterized by intense R&D, stringent regulatory hurdles, and susceptibility to weather patterns and commodity prices. The industry features a few large, integrated players (e.g., Bayer, Syngenta, BASF, Corteva) focused on patented molecules and seeds, and a fragmented landscape of generic/post-patent manufacturers.

UPL is one of the largest global agrochemical companies, positioning itself as a leader in "OpenAg" – an open innovation ecosystem. It has strategically grown through acquisitions (notably Arysta LifeScience) to become a significant player in the post-patent segment and a prominent force in the emerging bio-solutions market. UPL differentiates itself by offering a broad, diverse portfolio, robust supply chain, and global market access, often providing a "full basket" of solutions to farmers.

MOAT

Global Scale & Distribution Network: UPL operates in over 130 countries, possessing one of the most extensive global distribution and sales networks in the industry. This scale allows for significant market reach and cost efficiencies.

Broad Product Portfolio: A wide array of crop protection products (conventional and bio-solutions) catering to diverse crops and regional needs provides resilience against product-specific challenges and allows for cross-selling.

Backward Integration: Partial backward integration into manufacturing key active ingredients provides some cost control, supply chain stability, and quality assurance.

Regulatory Expertise: Navigating the complex and evolving global regulatory landscape for agrochemicals is a high barrier to entry. UPL's extensive experience and product registrations are a significant asset.

Innovation in Formulations & Bio-solutions: While not a primary discoverer of new molecules, UPL excels in developing new formulations, combinations, and application methods for existing active ingredients, as well as being a front-runner in the rapidly growing bio-solutions space.

Growth Drivers

Growing Global Food Demand: Increasing world population and changing dietary habits necessitate higher agricultural productivity and protection against crop losses.

Expansion of Bio-solutions Market: Increasing farmer and consumer preference for sustainable, eco-friendly agricultural practices drives demand for UPL's bio-solutions portfolio.

Geographical Expansion & Market Penetration: Deeper penetration in existing markets and strategic expansion into underserved regions.

Product Innovation: Continuous introduction of new formulations, integrated pest management solutions, and specialized products tailored to regional agricultural needs.

Synergies from Acquisitions: Realizing cost and revenue synergies from past acquisitions (e.g., Arysta LifeScience integration) to improve profitability and market share.

Digital Agriculture Adoption: Potential for growth through digital platforms that enhance product recommendations and farm management.

Risks

Regulatory Environment: Strict environmental regulations, bans on certain active ingredients (e.g., glyphosate, chlorpyrifos), and evolving registration processes can significantly impact product sales and increase R&D costs.

Weather Dependency & Crop Cycles: Agricultural demand is inherently tied to weather patterns, which can impact crop yields, farmer income, and their spending on inputs.

Commodity Price Volatility: Fluctuations in agricultural commodity prices directly affect farmer profitability and their purchasing power for agrochemicals.

Input Cost Volatility: Prices of raw materials (often petrochemical-derived) and energy can fluctuate significantly, impacting manufacturing costs and profit margins.

Currency Fluctuations: Extensive global operations expose UPL to significant currency risks, affecting reported revenues and profits.

Competition: Intense competition from both large multinational players and numerous generic manufacturers can lead to pricing pressure.

Debt Levels: Significant acquisitions have increased debt, requiring careful management of leverage and interest expenses.

Litigation & Environmental Concerns: Potential for lawsuits related to product safety, environmental impact, or competition.

Management & Ownership

UPL Ltd. is promoted by the Shroff family, with Mr. Rajnikant Shroff as the Founder Chairman and Mr. Jai Shroff as the Global CEO. The promoter group holds a significant stake in the company. Management is generally perceived as entrepreneurial and aggressive, particularly in its growth strategy through inorganic expansion (M&A). The company has a diverse board of directors. Ownership structure includes the promoter group, domestic institutional investors, foreign institutional investors, and public shareholders, typical for a large Indian listed company.

Outlook

UPL operates in a fundamental industry driven by long-term global food demand. The company's comprehensive portfolio, global distribution, and growing focus on sustainable solutions (bio-solutions) position it to capture market opportunities. The successful integration of past acquisitions and realization of planned synergies are crucial for margin expansion and debt reduction. However, the business faces inherent risks from stringent and evolving regulations on agrochemicals, volatile agricultural cycles, and commodity prices. Managing its debt levels effectively while continuing to innovate and expand its sustainable offerings will be key to its performance. The increasing global focus on sustainable agriculture also presents both an opportunity for its bio-solutions segment and a challenge for its conventional chemical portfolio, requiring constant adaptation and R&D.

UPL Share Price

Live · BSE / NSE · Inception: 1985
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

UPL Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 9887 14078 9067 11090 10907 15573 9216 12019 12269 18335
Other Income 151 126 98 111 170 107 143 250 92 178
Total Income 10038 14204 9165 11201 11077 15680 9359 12269 12361 18513
Total Expenditure 9794 12230 7966 9738 8951 12382 7820 10018 9952 14777
Operating Profit 244 1974 1199 1463 2126 3298 1539 2251 2409 3736
Interest 1191 1090 913 1070 730 914 1007 784 774 836
Depreciation 676 794 660 697 688 705 731 771 827 915
Exceptional Income / Expenses -17 -105 -49 -8 -76 -275 -9 142 -56 -16
Profit Before Tax -1640 -15 -423 -312 632 1404 -208 838 752 1969
Provision for Tax -59 110 72 138 -499 298 -14 172 181 598
Profit After Tax -1581 -125 -495 -450 1131 1106 -194 666 571 1371
Adjustments 364 165 111 7 -303 -210 106 -113 -175 -310
Profit After Adjustments -1217 40 -384 -443 828 896 -88 553 396 1061
Adjusted Earnings Per Share -15.6 0.5 -4.9 -5.7 10.7 11.3 -1.1 6.5 4.7 12.6

UPL Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 12091 14048 16312 17378 21837 35756 38694 46240 53576 43098 46637 51839
Other Income 206 316 495 429 332 266 259 296 477 483 486 663
Total Income 12296 14364 16807 17807 22169 36022 38953 46536 54053 43581 47123 52502
Total Expenditure 9827 11653 13331 13880 18080 28983 30343 36726 43380 38559 39037 42567
Operating Profit 2470 2711 3476 3927 4089 7039 8610 9810 10673 5022 8086 9935
Interest 632 704 782 791 998 1643 2060 2295 2963 3852 3627 3401
Depreciation 425 676 672 675 881 2012 2173 2359 2547 2763 2750 3244
Exceptional Income / Expenses -3 -129 -81 -63 -451 -623 -238 -324 -170 -252 -408 61
Profit Before Tax 1410 1117 1922 2305 1773 2764 4181 4966 5150 -2087 829 3351
Provision for Tax 244 165 189 275 198 586 686 529 736 -209 9 937
Profit After Tax 1166 952 1733 2030 1575 2178 3495 4437 4414 -1878 820 2414
Adjustments -22 -12 -6 -8 -84 -402 -624 -811 -844 678 77 -492
Profit After Adjustments 1144 940 1727 2022 1491 1776 2871 3626 3570 -1200 897 1922
Adjusted Earnings Per Share 17.1 14 21.8 25.4 18.7 22.3 36 45.5 45.7 -15.3 11.3 22.7

UPL Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 5860 5889 7397 9169 14715 19283 20887 21675 26858 24807 29213
Minority's Interest 44 44 33 19 3454 3312 3693 4647 8571 7899 8613
Borrowings 1694 2266 5350 5873 26382 27371 22141 24591 20144 24010 18263
Other Non-Current Liabilities 692 112 -97 -189 1622 1779 2417 1714 1306 374 22
Total Current Liabilities 5993 8168 7028 7642 16262 16685 19627 27976 29037 26861 28569
Total Liabilities 14284 16479 19711 22514 62435 68430 68765 80603 85916 83951 84680
Fixed Assets 4031 3862 4071 4437 32149 35322 34765 36193 38713 39056 39084
Other Non-Current Assets 1765 1410 1942 3053 3564 3866 3930 4682 5175 5567 5935
Total Current Assets 8489 11183 13658 15004 26696 29191 30015 39680 41988 39299 39617
Total Assets 14284 16479 19711 22514 62435 68430 68765 80603 85916 83951 84680

UPL Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1018 1046 1177 2877 2859 2826 6724 4797 5797 5967 5943
Cash Flow from Operating Activities 1409 1396 2585 2839 2356 8739 7212 6496 7751 2321 10151
Cash Flow from Investing Activities -331 -1719 -999 -2093 -30920 -2643 -2101 -3819 -1490 -2478 -1840
Cash Flow from Financing Activities -991 469 140 -801 28894 -2175 -6713 -1921 -6227 164 -4793
Net Cash Inflow / Outflow 86 146 1726 -55 330 3921 -1602 756 34 7 3518
Closing Cash & Cash Equivalent 973 1177 2880 2859 2827 6724 4797 5797 5967 5943 9478

UPL Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 17.07 13.98 21.83 25.35 18.69 22.27 36 45.46 45.66 -15.35 11.28
CEPS(Rs) 23.74 24.21 30.45 33.92 30.79 52.54 71.07 85.21 89.02 11.32 44.91
DPS(Rs) 3.21 3.21 4.49 5.13 5.13 5.77 9.62 9.62 9.62 0.96 6
Book NAV/Share(Rs) 87.43 31.08 92.6 114.96 184.5 204.34 224.44 271.52 343.23 317 367.46
Core EBITDA Margin(%) 18.72 16.7 17.87 16.41 14.58 16.15 18.32 17.38 15.82 8.54 13.5
EBIT Margin(%) 16.89 12.7 16.21 14.53 10.75 10.51 13.69 13.26 12.59 3.32 7.92
Pre Tax Margin(%) 11.67 7.79 11.52 10.82 6.88 6.59 9.17 9.07 7.99 -3.93 1.47
PAT Margin (%) 9.65 6.64 10.39 9.53 6.11 5.19 7.67 8.1 6.85 -3.53 1.46
Cash Profit Margin (%) 13.16 11.35 14.42 12.69 9.53 9.99 12.43 12.41 10.8 1.66 6.34
ROA(%) 8.63 6.19 9.58 9.62 3.71 3.33 5.09 5.94 5.3 -2.21 0.97
ROE(%) 21 23.95 36.86 24.63 13.19 14.05 20.44 22.43 18.2 -7.28 3.04
ROCE(%) 23.03 17.95 21.71 20.94 9.29 9.6 13.47 15.26 16.16 3.43 8.42
Receivable days 105.68 113.15 117.68 100.3 125.56 102.45 96.14 91.58 95 118.71 103.28
Inventory Days 81.78 85.56 86.91 74.46 96.79 73.9 69.15 75 76.63 91.88 74.86
Payable days 179.08 192.89 206.15 237.35 259.79 195.52 219.73 242.35 228.56 248.1 228.53
PER(x) 16.57 21.85 21.26 18.36 32.7 14.06 17.11 16.24 15.07 0 56.39
Price/Book(x) 3.23 9.83 5.01 4.05 3.31 1.53 2.74 2.72 2 1.38 1.73
Dividend Yield(%) 1.13 1.05 0.96 1.1 0.84 1.84 1.56 1.3 1.39 0.22 0.94
EV/Net Sales(x) 1.76 1.75 2.46 2.35 3.44 1.31 1.76 1.77 1.32 1.31 1.38
EV/Core EBITDA(x) 8.59 9.08 11.57 10.41 18.35 6.67 7.9 8.32 6.63 11.23 7.99
Net Sales Growth(%) 12.25 16.19 16.12 6.54 25.66 63.74 8.22 19.5 15.87 -19.56 8.21
EBIT Growth(%) 20.56 -10.83 48.49 14.5 -10.5 59.04 41.62 16.34 11.73 -78.24 152.46
PAT Growth(%) 24.76 -18.38 82.04 17.14 -22.41 38.29 60.47 26.95 -0.52 -142.55 143.66
EPS Growth(%) 20.45 -18.1 56.17 16.14 -26.26 19.11 61.66 26.3 0.42 -133.61 173.52
Debt/Equity(x) 0.56 2.52 0.86 0.72 1.98 1.49 1.14 1.33 0.86 1.14 0.81
Current Ratio(x) 1.42 1.37 1.94 1.96 1.64 1.75 1.53 1.42 1.45 1.46 1.39
Quick Ratio(x) 0.93 0.91 1.35 1.37 1.08 1.28 1.05 0.95 0.96 0.99 1.03
Interest Cover(x) 3.23 2.59 3.46 3.91 2.78 2.68 3.03 3.16 2.74 0.46 1.23
Total Debt/Mcap(x) 0.17 0.26 0.17 0.18 0.6 1.15 0.48 0.49 0.43 0.83 0.44

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +8% 0% +5% +14%
Operating Profit CAGR +61% -6% +3% +13%
PAT CAGR -43% -18% -3%
Share Price CAGR +1% 0% -4% +5%
ROE Average +3% +5% +11% +17%
ROCE Average +8% +9% +11% +14%

UPL Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 33.51 %
FII 41.78 %
DII (MF + Insurance) 14.65 %
Public (retail) 65.17 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 32.5232.5232.5232.5233.533.533.533.533.533.51
FII 34.3833.6434.5134.2232.5234.2234.937.0138.8441.78
DII 16.8215.3215.7417.6518.7118.3618.117.1616.7314.65
Public 64.1764.1764.1764.1663.5563.563.5763.6264.3565.17
Others 3.313.313.313.322.9432.932.872.151.32
Total 100100100100100100100100100100

UPL Peer Comparison

Pesticides & Agrochemicals Edit Columns

UPL Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

UPL Pros & Cons

Pros

  • Debtor days have improved from 248.1 to 228.53days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 33.51%.
  • Company has a low return on equity of 5% over the last 3 years.
  • The company has delivered a poor profit growth of -17% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp